Calcium Oxalate Urolithiasis
6
0
0
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Oxalobacter Formigenes Colonization and Urinary Oxalate Excretion
Pilot Study to Evaluate the Contribution of Gene Variants to Idiopathic Urolithiasis
Evaluating the Bacterial and Fungal Microbiome in Patients With Calcium Oxalate Urolithiasis and Renal Cell Carcinoma
Evaluating the Vitamin K2 Status of Calcium-based Stone Formers
Mineral Water for Prevention of Renal Stones
Patient Compliance for Metabolic Evaluation and Medical Management in Calcium Stone Patients